Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10847) 10847
Magazine Article (105) 105
Newspaper Article (43) 43
Book Chapter (26) 26
Newsletter (20) 20
Dissertation (10) 10
Book / eBook (7) 7
Conference Proceeding (7) 7
Book Review (4) 4
Publication (2) 2
Report (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8446) 8446
streptokinase - therapeutic use (4835) 4835
male (3621) 3621
streptokinase (3272) 3272
female (3260) 3260
middle aged (3030) 3030
myocardial infarction - drug therapy (2829) 2829
science & technology (2527) 2527
life sciences & biomedicine (2478) 2478
aged (2240) 2240
adult (2132) 2132
streptokinase - administration & dosage (2078) 2078
biological and medical sciences (2071) 2071
abridged index medicus (2040) 2040
medical sciences (1874) 1874
thrombolytic therapy (1582) 1582
fibrinolytic agents - therapeutic use (1527) 1527
pharmacology. drug treatments (1224) 1224
time factors (1219) 1219
animals (1171) 1171
deoxyribonuclease i (1074) 1074
cardiovascular system & cardiology (1063) 1063
streptokinase - adverse effects (1060) 1060
old medline (995) 995
blood. blood coagulation. reticuloendothelial system (922) 922
fibrinolysis (922) 922
tissue plasminogen activator - therapeutic use (910) 910
cardiac & cardiovascular systems (890) 890
heparin - therapeutic use (860) 860
streptokinase - pharmacology (826) 826
thrombosis - drug therapy (781) 781
streptodornase and streptokinase (728) 728
urokinase-type plasminogen activator - therapeutic use (633) 633
myocardial infarction - mortality (611) 611
electrocardiography (583) 583
fibrinolytic agents - administration & dosage (564) 564
myocardial infarction - physiopathology (556) 556
treatment outcome (522) 522
thrombophlebitis - drug therapy (514) 514
pulmonary embolism - drug therapy (508) 508
myocardial infarction (500) 500
clinical trials as topic (491) 491
thrombolysis (489) 489
general & internal medicine (487) 487
acute disease (486) 486
myocardial infarction - therapy (469) 469
follow-up studies (468) 468
fibrinolysis - drug effects (439) 439
medicine, general & internal (419) 419
coronary angiography (418) 418
heart (410) 410
cardiology. vascular system (405) 405
recurrence (405) 405
plasminogen (404) 404
adolescent (392) 392
streptodornase and streptokinase - therapeutic use (392) 392
drug therapy, combination (390) 390
infusions, intravenous (385) 385
fibrinolytic agents - adverse effects (370) 370
streptokinase - metabolism (370) 370
thrombolytic therapy - methods (361) 361
coronary heart disease (353) 353
injections, intravenous (348) 348
plasminogen - metabolism (348) 348
thrombolytic therapy - adverse effects (348) 348
drug therapy (344) 344
thrombosis (328) 328
prospective studies (325) 325
prognosis (323) 323
heart attack (321) 321
rabbits (307) 307
child (302) 302
research (298) 298
fibrinolysin (295) 295
anticoagulants - therapeutic use (294) 294
myocardial infarction - diagnostic imaging (293) 293
heparin - administration & dosage (290) 290
aged, 80 and over (286) 286
peripheral vascular disease (285) 285
angiography (282) 282
myocardial infarction - blood (280) 280
blood coagulation tests (271) 271
myocardial infarction - diagnosis (271) 271
dogs (269) 269
in vitro techniques (267) 267
radiography (264) 264
research article (263) 263
myocardial infarction - complications (262) 262
infusions, intra-arterial (260) 260
retrospective studies (258) 258
tissue plasminogen activator (258) 258
tissue plasminogen activator - administration & dosage (256) 256
plasminogen activators - therapeutic use (254) 254
angioplasty, balloon (248) 248
infusions, parenteral (245) 245
random allocation (244) 244
thromboembolism - drug therapy (242) 242
combined modality therapy (236) 236
coronary disease - drug therapy (236) 236
coronary vessels (236) 236
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8375) 8375
German (1085) 1085
French (390) 390
Russian (308) 308
Italian (218) 218
Spanish (205) 205
Polish (188) 188
Japanese (132) 132
Portuguese (86) 86
Czech (74) 74
Danish (36) 36
Dutch (32) 32
Hungarian (30) 30
Swedish (27) 27
Norwegian (25) 25
Romanian (24) 24
Ukrainian (19) 19
Chinese (17) 17
Turkish (15) 15
Hebrew (14) 14
Croatian (12) 12
Bulgarian (11) 11
Slovak (11) 11
Finnish (9) 9
Persian (9) 9
Serbian (5) 5
Afrikaans (2) 2
Korean (2) 2
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Functional differences between Streptococcus pyogenes cluster 1 and cluster 2b streptokinases are determined by their [beta]-domains
by Zhang, Yueling and Liang, Zhong and Glinton, Kristofor and Ploplis, Victoria A and Castellino, Francis J
FEBS letters, ISSN 0014-5793, 05/2013, Volume 587, Issue 9, p. 1304
Streptokinase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Assessing Role of Higher dose of Streptokinase for Improving the Efficacy of Percutaneous Drainage in Pancreatic Necrosis
by Vaswani, Prateek and Gupta, Rajesh and Kang, Mandeep and Rana, Surinder S and Krishnamurthy, Gautham and Bhasin, Deepak K and Khullar, Madhu and Singh, Rajinder
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S289 - S289
Gastroenterology and Hepatology | Streptokinase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cell‐free production of a therapeutic protein: Expression, purification, and characterization of recombinant streptokinase using a CHO lysate
by Tran, Kevin and Gurramkonda, Chandrasekhar and Cooper, Merideth A and Pilli, Manohar and Taris, Joseph E and Selock, Nicholas and Han, Tzu‐Chiang and Tolosa, Michael and Zuber, Adil and Peñalber‐Johnstone, Chariz and Dinkins, Christina and Pezeshk, Niloufar and Kostov, Yordan and Frey, Douglas D and Tolosa, Leah and Wood, David W and Rao, Govind
Biotechnology and bioengineering, ISSN 0006-3592, 01/2018, Volume 115, Issue 1, pp. 92 - 102
cell‐free in vitro translation | green fluorescent protein | mini‐bioreactors | intein technology | mini-bioreactors | cell-free in vitro translation | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Green Fluorescent Proteins - isolation & purification | Streptokinase - biosynthesis | Streptokinase - genetics | Cricetulus | Green Fluorescent Proteins - genetics | Recombinant Proteins - genetics | Recombinant Proteins - biosynthesis | Recombinant Proteins - isolation & purification | Animals | Complex Mixtures | Cell-Free System | Green Fluorescent Proteins - biosynthesis | Streptokinase - isolation & purification | CHO Cells | Usage | Fluorescence | Monoclonal antibodies | Protein biosynthesis | Health aspects | Recombinant proteins | Cells | Biopharmaceutics | Disulfide bonds | Purification | Protein purification | Cell-free system | Glycosylation | Mammalian cells | Proteins | Streptokinase | Protein synthesis | Bioreactors | Technology | Production methods | Green fluorescent protein | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. INDIGENOUS RECOMBINANT STREPTOKINASE VS NATURAL STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION PATIENTS: PHASE III MULTICENTRIC RANDOMIZED DOUBLE BLIND TRIAL
by Diwedi, S. K and Hiremath, J. S and Kerkar, P. G and Reddy, Krishna N and Manjunath, C. N and Ramesh, S. S and Prabhavati, S and Dhobe, M and Singh, Kavita and Bhusari, P and Rao, Raman
INDIGENOUS RECOMBINANT STREPTOKINASE VS NATURAL STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION PATIENTS: PHASE III MULTICENTRIC RANDOMIZED DOUBLE BLIND TRIAL, 12/2005
Streptokinase, Recombinant streptokinase, Myocardial infarction, Thrombolysis
Journal
Details down arrow
5. Site-specific thiol-mediated pegylation of streptokinase leads to improved properties with clinical potential
by Sawhney, Pooja and Kumar, Shekhar and Maheshwari, Neeraj and Guleria, Sumeet Singh and Dhar, Neelam and Kashyap, Radhika and Sahni, Girish
Current pharmaceutical design, ISSN 1381-6128, 10/2016, Volume 22, Issue 38, pp. 5868 - 5878
PEGylation | Streptokinase | Immune-reactivity | Improved thrombolytic with clinical potential | Half-life | Clot lysis | Proteolytic stability | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Polyethylene Glycols - metabolism | Streptokinase - chemistry | Streptococcus - enzymology | Streptokinase - genetics | Sulfhydryl Compounds - metabolism | Humans | Models, Molecular | Crystallography, X-Ray | Polyethylene Glycols - chemistry | Sulfhydryl Compounds - chemistry | Protein Stability | Streptokinase - metabolism
Journal Article
Details down arrow
6. Full Text Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
by Maryam Rafipour and Malihe Keramati and Mohammad Mehdi Aslani and Arash Arashkia and Farzin Roohvand
Iranian biomedical journal, ISSN 1028-852X, 01/2020, Volume 24, Issue 1, pp. 15 - 23
plasminogen | streptokinase | thrombolytic therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Engineering, expression and purification of a chimeric fibrin-specific streptokinase
by Taheri, Mohammad Naser and Behzad-Behbahani, Abbas and Rafiei Dehbidi, Gholamreza and Salehi, Saeede and Sharifzadeh, Sedigheh
Protein expression and purification, ISSN 1046-5928, 12/2016, Volume 128, pp. 14 - 21
Chromogenic substrate assay | Kringle 2 | Fibrin-binding streptokinase | Fibrinolytic agent | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Biochemical Research Methods | Science & Technology | Recombinant Fusion Proteins - isolation & purification | Tissue Plasminogen Activator - isolation & purification | Humans | Bacterial Proteins - chemistry | Tissue Plasminogen Activator - chemistry | Tissue Plasminogen Activator - genetics | Streptokinase - chemistry | Fibrin - chemistry | Escherichia coli - metabolism | Protein Engineering | Recombinant Fusion Proteins - biosynthesis | Streptokinase - biosynthesis | Streptokinase - genetics | Bacterial Proteins - genetics | Recombinant Fusion Proteins - chemistry | Fibrinolysis | Streptococcus - enzymology | Tissue Plasminogen Activator - biosynthesis | Streptococcus - genetics | Escherichia coli - genetics | Recombinant Fusion Proteins - genetics | Streptokinase - isolation & purification | Bacterial Proteins - biosynthesis | Fibrin - metabolism | Bacterial Proteins - isolation & purification | Stroke (Disease) | Fibrin | Tissue plasminogen activator | Analysis | Escherichia coli | Recombinant proteins | Protein binding | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Streptokinase variants from Streptococcus pyogenes isolates display altered plasminogen activation characteristics – implications for pathogenesis
by Cook, Simon M and Skora, Amanda and Gillen, Christine M and Walker, Mark J and McArthur, Jason D
Molecular microbiology, ISSN 0950-382X, 12/2012, Volume 86, Issue 5, pp. 1052 - 1062
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Miscellaneous | Bacteriology | Amino Acid Sequence | Streptococcal Infections - microbiology | Catalytic Domain | Streptokinase - genetics | Plasminogen Activators | Humans | Virulence | Molecular Sequence Data | Mice, Transgenic | Plasminogen - metabolism | Sequence Analysis, DNA | Streptococcal Infections - mortality | Genetic Variation | Streptococcus pyogenes - genetics | Streptokinase - chemistry | Streptococcus pyogenes - pathogenicity | Animals | Plasminogen - chemistry | Streptococcus pyogenes - enzymology | Mice | Mutation | Streptokinase - metabolism | Analysis | Streptokinase | Bacteria | Molecular biology | Kinases | Pathogenesis | Plasmids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism
by Verhamme, Ingrid M and Bock, Paul E
The Journal of biological chemistry, ISSN 0021-9258, 10/2014, Volume 289, Issue 40, pp. 28006 - 28018
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Streptococcal Infections - microbiology | Streptokinase - genetics | Biocatalysis | Humans | Bacterial Proteins - chemistry | Bacterial Proteins - genetics | Plasminogen - genetics | Substrate Specificity | Plasminogen - metabolism | Streptococcal Infections - enzymology | Streptococcus - chemistry | Amino Acid Motifs | Streptokinase - chemistry | Fibrinolysin - chemistry | Streptococcus - enzymology | Streptococcus - genetics | Plasminogen - chemistry | Protein Binding | Bacterial Proteins - metabolism | Protein Conformation | Kinetics | Binding Sites | Fibrinolysin - metabolism | Streptokinase - metabolism | Index Medicus | Streptokinase | Bacterial Pathogenesis | Fluorescence | Enzymology | Fibrinolysis | Plasmin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection
by Maskell, Nicholas A and Davies, Robert J.O and Davies, Christopher W.H and Nunn, Andrew J and Hedley, Emma L and Gleeson, Fergus V and Miller, Robert and Gabe, Rhian and Rees, Glyn L and Peto, Timothy E.A and Woodhead, Mark A and Lane, Donald J and Darbyshire, Janet H and MIST1 Grp and First Multicenter Intrapleural Sepsis Trial (MIST1) Group
The New England journal of medicine, ISSN 0028-4793, 03/2005, Volume 352, Issue 9, pp. 865 - 874
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Instillation, Drug | Humans | Middle Aged | Male | Lung - diagnostic imaging | Empyema, Pleural - mortality | Anti-Bacterial Agents - therapeutic use | Fibrinolytic Agents - adverse effects | Community-Acquired Infections - drug therapy | Fibrinolytic Agents - therapeutic use | Pleural Diseases - diagnostic imaging | Female | Length of Stay | Pleural Diseases - drug therapy | Pleural Diseases - surgery | Streptokinase - adverse effects | Empyema, Pleural - surgery | Double-Blind Method | Bacterial Infections - diagnostic imaging | Bacterial Infections - drug therapy | United Kingdom | Combined Modality Therapy | Pleural Diseases - mortality | Streptokinase - therapeutic use | Bacterial Infections - surgery | Cross Infection - drug therapy | Empyema, Pleural - drug therapy | Drainage | Radiography | Pneumonia - complications | Bacterial Infections - mortality | Dosage and administration | Streptokinase | Research | Drug therapy | Pleural diseases | Clinical trials | Infections | Respiratory diseases | Surgery | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Liposomal nanocarriers for plasminogen activators
by Koudelka, Stepan and Mikulik, Robert and Mašek, Josef and Raška, Milan and Turánek Knotigová, Pavlína and Miller, Andrew D and Turánek, Jaroslav
Journal of controlled release, ISSN 0168-3659, 04/2016, Volume 227, pp. 45 - 57
Fibrin | Urokinase | Stroke | Streptokinase | Tissue plasminogen activator | RGD peptide | Thrombus | Protein delivery | Liposomes | Platelets | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Fibrinolysin - therapeutic use | Nanostructures - ultrastructure | Metalloendopeptidases - therapeutic use | Urokinase-Type Plasminogen Activator - therapeutic use | Humans | Fibrinolysin - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Metalloendopeptidases - administration & dosage | Tissue Plasminogen Activator - therapeutic use | Streptokinase - therapeutic use | Liposomes - chemistry | Animals | Streptokinase - administration & dosage | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Nanostructures - chemistry | Fibrinolytic Agents - administration & dosage | Thromboembolism - drug therapy | Liposomes - ultrastructure | Urokinase-Type Plasminogen Activator - administration & dosage | Proteins | Thrombolytic drugs | Health aspects | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen activation: A Domain-Exchange Study
by Rafipour, Maryam and Keramati, Malihe and Aslani, Mohammad Mehdi and Arashkia, Arash and Roohvand, Farzin and Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran and Department of Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran and Department of Virology, Pasteur Institute of Iran, Tehran, Iran
Iranian biomedical journal, ISSN 1028-852X, 01/2020, Volume 24, Issue 1, pp. 15 - 23
Streptokinase - chemistry | Streptococcus - enzymology | Streptokinase - genetics | Proteolysis | Protein Domains | Amides - metabolism | Plasminogen - metabolism | Streptokinase - isolation & purification | Kinetics | Fibrin - metabolism | Exchanging | Sodium lauryl sulfate | Gel electrophoresis | Variable region | Activation | Colorimetry | Gene expression | Domains | Fibrin | Streptokinase | E coli | Plasmids | Fibrinogen | Nickel | Plasminogen | Full Length | Thrombolytic therapy | plasminogen | streptokinase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights